News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
227,953 Results
Type
Article (7181)
Company Profile (16)
Press Release (220756)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (63162)
Career Advice (294)
Deals (14770)
Drug Delivery (28)
Drug Development (36806)
Employer Resources (24)
FDA (6414)
Job Trends (4910)
News (121855)
Policy (11628)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
Academia (567)
Accelerated approval (2)
Adcomms (7)
Allergies (35)
Alliances (14773)
ALS (28)
Alzheimer's disease (600)
Antibody-drug conjugate (ADC) (40)
Approvals (6460)
Artificial intelligence (102)
Autoimmune disease (10)
Automation (3)
Bankruptcy (147)
Best Places to Work (4609)
BIOSECURE Act (2)
Biosimilars (21)
Biotechnology (18)
Bladder cancer (49)
Brain cancer (14)
Breast cancer (106)
Cancer (1129)
Cardiovascular disease (70)
Career advice (258)
Career pathing (4)
CAR-T (89)
Cell therapy (215)
Cervical cancer (12)
Clinical research (31186)
Collaboration (303)
Compensation (89)
Complete response letters (7)
COVID-19 (723)
CRISPR (18)
C-suite (74)
Cystic fibrosis (37)
Data (1278)
Denatured (1)
Depression (19)
Diabetes (109)
Diagnostics (2229)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (48)
Drug pricing (41)
Drug shortages (17)
Duchenne muscular dystrophy (40)
Earnings (33300)
Editorial (13)
Employer branding (1)
Employer resources (19)
Events (30999)
Executive appointments (247)
FDA (7078)
Featured Employer (3)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (269)
Gene editing (46)
Generative AI (10)
Gene therapy (127)
GLP-1 (184)
Government (1253)
Grass and pollen (2)
Guidances (35)
Healthcare (6139)
Huntington's disease (5)
IgA nephropathy (14)
Immunology and inflammation (36)
Indications (17)
Infectious disease (785)
Inflammatory bowel disease (58)
Inflation Reduction Act (5)
Influenza (24)
Intellectual property (51)
Interviews (45)
IPO (8030)
IRA (17)
Job creations (571)
Job search strategy (221)
Kidney cancer (8)
Labor market (5)
Layoffs (40)
Leadership (3)
Legal (2100)
Liver cancer (38)
Lung cancer (161)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (104)
MASH (37)
Medical device (4582)
Medtech (4583)
Mergers & acquisitions (7093)
Metabolic disorders (279)
Multiple sclerosis (38)
NASH (8)
Neurodegenerative disease (25)
Neuropsychiatric disorders (4)
Neuroscience (803)
NextGen: Class of 2025 (1501)
Non-profit (712)
Northern California (1264)
Obesity (138)
Opinion (75)
Ovarian cancer (53)
Pain (35)
Pancreatic cancer (46)
Parkinson's disease (66)
Partnered (5)
Patents (133)
Patient recruitment (61)
Peanut (17)
People (14552)
Pharmaceutical (8)
Pharmacy benefit managers (6)
Phase I (9954)
Phase II (13721)
Phase III (10294)
Pipeline (729)
Policy (32)
Postmarket research (796)
Preclinical (3627)
Press Release (9)
Prostate cancer (50)
Psychedelics (11)
Radiopharmaceuticals (118)
Rare diseases (156)
Real estate (1003)
Recruiting (7)
Regulatory (9145)
Reports (13)
Research institute (510)
Resumes & cover letters (39)
Rett syndrome (3)
RNA editing (2)
RSV (16)
Schizophrenia (26)
Series A (45)
Series B (31)
Service/supplier (2)
Sickle cell disease (23)
Southern California (1100)
Special edition (2)
Spinal muscular atrophy (31)
Sponsored (14)
Startups (679)
Stomach cancer (5)
Supply chain (25)
Tariffs (3)
The Weekly (1)
United States (10538)
Vaccines (167)
Venture capitalists (5)
Weight loss (76)
Women's health (6)
Worklife (4)
Date
Today (67)
Last 7 days (266)
Last 30 days (1175)
Last 365 days (15824)
2025 (4589)
2024 (16927)
2023 (19104)
2022 (22250)
2021 (23640)
2020 (21802)
2019 (14444)
2018 (10641)
2017 (11457)
2016 (9547)
2015 (11740)
2014 (8103)
2013 (5878)
2012 (6043)
2011 (6749)
2010 (6218)
Location
Africa (176)
Alabama (16)
Alaska (2)
Arizona (54)
Arkansas (3)
Asia (17552)
Australia (4848)
California (2855)
Canada (1115)
China (237)
Colorado (121)
Connecticut (161)
Delaware (58)
Europe (28004)
Florida (421)
Georgia (68)
Idaho (6)
Illinois (206)
India (20)
Indiana (123)
Japan (89)
Kansas (14)
Kentucky (5)
Louisiana (5)
Maine (36)
Maryland (351)
Massachusetts (2036)
Michigan (51)
Minnesota (102)
Missouri (35)
Montana (11)
Nebraska (8)
Nevada (39)
New Hampshire (36)
New Jersey (984)
New Mexico (3)
New York (907)
North Carolina (391)
North Dakota (2)
Northern California (1264)
Ohio (62)
Oklahoma (1)
Oregon (7)
Pennsylvania (669)
Puerto Rico (6)
Rhode Island (8)
South America (302)
South Carolina (11)
Southern California (1100)
Tennessee (42)
Texas (428)
Utah (67)
Virginia (76)
Washington D.C. (17)
Washington State (343)
West Virginia (2)
Wisconsin (11)
227,953 Results for "immunocore limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunocore to present at upcoming investor conferences
April 2, 2025
·
1 min read
Press Releases
Immunocore to present at upcoming March 2025 investor conferences
March 4, 2025
·
1 min read
Press Releases
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
March 11, 2025
·
9 min read
Press Releases
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
February 27, 2025
·
29 min read
BioCapital
Immunocore to present at the Jefferies Global Healthcare Conference
Immunocore Holdings plc today announced that management will participate in the Jefferies Global Healthcare Conference.
May 30, 2024
·
6 min read
Press Releases
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
February 19, 2025
·
6 min read
Press Releases
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Press Releases
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
·
22 min read
Press Releases
Immunocore to present at upcoming November 2024 investor conferences
November 11, 2024
·
1 min read
BioCapital
Immunocore presented two posters at CROI 2024
Immunocore Holdings plc presented two posters at the 2024 Conference on Retroviruses and Opportunistic Infections.
March 5, 2024
·
2 min read
1 of 22,796
Next
